VanEck Pharmaceutical ETF (PPH) Short Interest Ratio & Short Volume → Urgent Nvidia Warning (From Altimetry) (Ad) Free PPH Stock Alerts $87.41 -0.55 (-0.63%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Pharmaceutical ETF Short Interest DataCurrent Short Volume1,400,000 sharesPrevious Short Volume1,580,000 sharesChange Vs. Previous Month-11.39%Dollar Volume Sold Short$119.62 millionShort Interest Ratio / Days to Cover11.3Last Record DateApril 15, 2024Outstanding Shares5,740,000 sharesPercentage of Shares Shorted24.39%Today's Trading Volume128,128 sharesAverage Trading Volume140,470 sharesToday's Volume Vs. Average91% Short Selling VanEck Pharmaceutical ETF ? Sign up to receive the latest short interest report for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPPH Short Interest Over TimePPH Days to Cover Over TimePPH Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. VanEck Pharmaceutical ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,400,000 shares $119.62 million -11.4%N/A11.3 $85.44 3/31/20248,700 shares $789,090.00 -99.5%N/A0.1 $90.70 3/15/20241,570,000 shares $140.59 million -8.7%N/A13 $89.55 2/29/20241,720,000 shares $152.74 million +5.5%N/A14.9 $88.80 2/15/20241,630,000 shares $144.16 million -22.4%N/A14.9 $88.44 1/31/20242,100,000 shares $179.13 million -0.5%N/A18.6 $85.30 Get the Latest News and Ratings for PPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,110,000 shares $180.57 million +14.7%N/A19.3 $85.58 12/31/20231,840,000 shares $149.71 million -4.7%N/A16.5 $81.37 12/15/20231,930,000 shares $152.10 million -18.9%N/A18 $78.81 11/30/20232,380,000 shares $186.85 million -1.2%N/A21.7 $78.51 11/15/20232,410,000 shares $184.75 million +4.3%N/A20.9 $76.66 10/31/20232,310,000 shares $173.97 million +4.5%N/A18.7 $75.31 10/15/20232,210,000 shares $177.00 million -1.3%N/A17.3 $80.09 9/30/20232,240,000 shares $178.89 million -1.3%N/A17.2 $79.86 9/15/20232,270,000 shares $186.03 million -2.6%N/A16.7 $81.95 8/31/20232,330,000 shares $190.83 million +16.5%N/A17.2 $81.90 8/15/20232,000,000 shares $165.46 million -17.0%N/A15.6 $82.73 7/31/20232,410,000 shares $193.81 million -0.4%N/A19.2 $80.42 7/15/20232,420,000 shares $188.49 million +5.2%N/A20.7 $77.89 6/30/20232,300,000 shares $181.17 million +0.4%N/A20.1 $78.77 6/15/20232,290,000 shares $179.70 million +19.9%N/A21.6 $78.47 5/31/20231,910,000 shares $144.49 million -12.8%N/A16.6 $75.65 5/15/20232,190,000 shares $172.48 million -10.3%N/A16.7 $78.76 4/30/20232,440,000 shares $192.44 million +1.2%N/A17.7 $78.87 4/15/20232,410,000 shares $191.59 million +3.9%N/A14.3 $79.50 3/31/20232,320,000 shares $180.10 million +19.0%N/A14.4 $77.63 3/15/20231,950,000 shares $144.65 million -18.8%N/A12.1 $74.18 2/28/20232,400,000 shares $181.56 million +8.1%N/A15.1 $75.65 2/15/20232,220,000 shares $173.74 million -7.5%N/A15.4 $78.26 1/31/20232,400,000 shares $188.02 million -0.4%N/A16.8 $78.34 1/15/20232,410,000 shares $191.60 million +4.8%N/A17.1 $79.50 12/30/20222,300,000 shares $178.80 million -3.8%N/A18.4 $77.74 12/15/20222,390,000 shares $186.68 million +7.2%N/A16 $78.11 11/30/20222,230,000 shares $171.78 million +10.4%N/A14.5 $77.03 11/15/20222,020,000 shares $147.97 million +27.9%N/A12.5 $73.25 10/31/20221,580,000 shares $115.10 million +6.8%N/A10.1 $72.85 10/15/20221,480,000 shares $101.05 million No ChangeN/A8.8 $68.28 9/30/20222,150,000 shares $144.57 million +4.9%N/A13 $67.24 9/15/20222,050,000 shares $144.94 million -10.1%N/A13 $70.70 8/31/20222,280,000 shares $161.29 million +31.0%N/A12.7 $70.74Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… PPH Short Interest - Frequently Asked Questions What is VanEck Pharmaceutical ETF's current short interest? Short interest is the volume of VanEck Pharmaceutical ETF shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,400,000 shares of PPH short. Learn More on VanEck Pharmaceutical ETF's current short interest. What is a good short interest ratio for VanEck Pharmaceutical ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPH shares currently have a short interest ratio of 11.0. Learn More on VanEck Pharmaceutical ETF's short interest ratio. Is VanEck Pharmaceutical ETF's short interest increasing or decreasing? VanEck Pharmaceutical ETF saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 1,400,000 shares, a decrease of 11.4% from the previous total of 1,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Pharmaceutical ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Pharmaceutical ETF: VanEck Biotech ETF (0.09%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (2.28%), Principal Healthcare Innovators ETF (0.32%), Invesco Nasdaq Biotechnology ETF (1.75%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (7.88%), and iShares Biotechnology ETF (15.82%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Pharmaceutical ETF stock? Short selling PPH is an investing strategy that aims to generate trading profit from VanEck Pharmaceutical ETF as its price is falling. PPH shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Pharmaceutical ETF? A short squeeze for VanEck Pharmaceutical ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPH, which in turn drives the price of the stock up even further. How often is VanEck Pharmaceutical ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BBH Short Interest Data PSCH Short Interest Data BIB Short Interest Data BTEC Short Interest Data IBBQ Short Interest Data FTXH Short Interest Data JDOC Short Interest Data BIS Short Interest Data IBB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPH) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & Company